Renaissance Technologies’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,676
| Closed | -$62K | – | 4634 |
|
|
2022
Q1 | $62K | Sell |
1,676
-1,434
| -46% | -$51.6K | ﹤0.01% | 3877 |
|
|
2021
Q4 | $110K | Sell |
3,110
-304
| -9% | -$16K | ﹤0.01% | 3660 |
|
|
2021
Q3 | $256K | Buy |
3,414
+2,304
| +208% | +$164K | ﹤0.01% | 3128 |
|
|
2021
Q2 | $97K | Buy |
+1,110
| New | +$106K | ﹤0.01% | 3363 |
|
|
2020
Q3 | – | Sell |
-181
| Closed | -$14K | – | 3759 |
|
|
2020
Q2 | $14K | Hold |
181
| – | – | ﹤0.01% | 3378 |
|
|
2020
Q1 | $9K | Sell |
181
-323
| -64% | -$29.5K | ﹤0.01% | 3392 |
|
|
2019
Q4 | $46K | Sell |
504
-274
| -35% | -$25.5K | ﹤0.01% | 3395 |
|
|
2019
Q3 | $80K | Sell |
778
-155
| -17% | -$33.6K | ﹤0.01% | 3288 |
|
|
2019
Q2 | $275K | Sell |
933
-168
| -15% | -$59.2K | ﹤0.01% | 3203 |
|
|
2019
Q1 | $512K | Buy |
1,101
+770
| +233% | +$299K | ﹤0.01% | 2916 |
|
|
2018
Q4 | $97K | Hold |
331
| – | – | ﹤0.01% | 3237 |
|
|
2018
Q3 | $58K | Hold |
331
| – | – | ﹤0.01% | 3276 |
|
|
2018
Q2 | $65K | Sell |
331
-13
| -4% | -$2.4K | ﹤0.01% | 3173 |
|
|
2018
Q1 | $50K | Buy |
344
+13
| +4% | +$2.54K | ﹤0.01% | 3300 |
|
|
2017
Q4 | $78K | Hold |
331
| – | – | ﹤0.01% | 3242 |
|
|
2017
Q3 | $67K | Sell |
331
-983
| -75% | -$181K | ﹤0.01% | 3110 |
|
|
2017
Q2 | $131K | Sell |
1,314
-820
| -38% | -$130K | ﹤0.01% | 3054 |
|
|
2017
Q1 | $640K | Sell |
2,134
-946
| -31% | -$278K | ﹤0.01% | 2691 |
|
|
2016
Q4 | $1.11M | Sell |
3,080
-973
| -24% | -$363K | ﹤0.01% | 2504 |
|
|
2016
Q3 | $1.39M | Sell |
4,053
-400
| -9% | -$140K | ﹤0.01% | 2403 |
|
|
2016
Q2 | $1.45M | Sell |
4,453
-715
| -14% | -$257K | ﹤0.01% | 2373 |
|
|
2016
Q1 | $1.72M | Buy |
5,168
+290
| +6% | +$95.6K | ﹤0.01% | 2310 |
|
|
2015
Q4 | $2.19M | Buy |
4,878
+3,750
| +332% | +$2.35M | ﹤0.01% | 2044 |
|
|
2015
Q3 | $993K | Buy |
1,128
+810
| +255% | +$1.18M | ﹤0.01% | 2385 |
|
|
2015
Q2 | $893K | Buy |
318
+262
| +468% | +$1.1M | ﹤0.01% | 2500 |
|
|
2015
Q1 | $302K | Buy |
56
+54
| +2,700% | +$310K | ﹤0.01% | 2766 |
|
|
2014
Q4 | $9K | Buy |
+2
| New | +$16.8K | ﹤0.01% | 2932 |
|
|
2014
Q3 | – | Sell |
-64
| Closed | -$745K | – | 2981 |
|
|
2014
Q2 | $745K | Buy |
64
+60
| +1,500% | +$670K | ﹤0.01% | 2162 |
|
|
2014
Q1 | $52K | Sell |
4
-86
| -96% | -$1.11M | ﹤0.01% | 2753 |
|
|
2013
Q4 | $1.24M | Buy |
90
+46
| +105% | +$611K | ﹤0.01% | 1977 |
|
|
2013
Q3 | $671K | Buy |
44
+6
| +16% | +$95.3K | ﹤0.01% | 2192 |
|
|
2013
Q2 | $701K | Buy |
+38
| New | +$720K | ﹤0.01% | 2097 |
|
Other funds holding CSCI
VF
Renaissance Technologies's CSCI Position: Q2 2022 in Review
Renaissance Technologies sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q2 2022, closing a stake of 1,676 shares — an estimated $62K sold.
Renaissance Technologies first reported a position in CSCI in Q2 2013 and held it in 32 quarters. The position peaked at $2.19M in Q4 2015. 29 funds tracked by Wall St. Rank hold CSCI as of Q2 2022.
- Renaissance Technologies reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- Renaissance Technologies sold 1,676 COSCIENS Biopharma Inc. Common Stock shares in Q2 2022, an estimated $62K.
- Renaissance Technologies first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2013 and held it in 32 quarters.
- Renaissance Technologies's COSCIENS Biopharma Inc. Common Stock position peaked at $2.19M in Q4 2015.
- 29 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q2 2022.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.